(Q40466224)

20 September 2017

1 reference

title

Why do so many haemophilia A patients develop an inhibitor? (English)

1 reference

20 September 2017

0 references

0 references

Hoyer LW

1

1 reference

PubMed ID

7646985

20 September 2017

language of work or name

English

0 references

publication date

1 July 1995

1 reference

British Journal of Haematology

20 September 2017

1 reference

20 September 2017

90

1 reference

20 September 2017

498-501

1 reference

20 September 2017

3

1 reference

Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII.

20 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05575.X

Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05575.X

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05575.X

Genetic predisposition to develop factor VIII antibody in classic hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05575.X

Factor VIII gene rearrangements in patients with severe haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05575.X

Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05575.X

Factor VIII and factor IX inhibitors in haemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05575.X

Intron 22 inversions and haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05575.X

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05575.X

Spectrum of mutations in CRM-positive and CRM-reduced hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05575.X

Analysis of factor VIII mRNA reveals defects in everyone of 28 haemophilia A patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05575.X

Incidence of inhibitors in patients with severe and moderate hemophilia A treated with factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05575.X

Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene, second edition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05575.X

10.1111/J.1365-2141.1995.TB05575.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

7646985